Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
74,869,792
-
Total 13F shares
-
66,502,275
-
Share change
-
-1,705,681
-
Total reported value
-
$834,701,900
-
Put/Call ratio
-
604%
-
Price per share
-
$12.55
-
Number of holders
-
161
-
Value change
-
-$15,271,356
-
Number of buys
-
64
-
Number of sells
-
75
Institutional Holders of Zymeworks Inc. - Common Stock, $0.00001 par value per share (ZYME) as of Q3 2024
As of 30 Sep 2024,
Zymeworks Inc. - Common Stock, $0.00001 par value per share (ZYME) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,502,275 shares.
The largest 10 holders included
EcoR1 Capital, LLC, MORGAN STANLEY, Redmile Group, LLC, BVF INC/IL, BlackRock, Inc., Rubric Capital Management LP, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BNP PARIBAS ASSET MANAGEMENT Holding S.A., and DEUTSCHE BANK AG\.
This page lists
161
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.